‘If single-minded focus on development agenda continues, success will follow’
Rating: 4/ 5 It has been an impressive start by the Prime Minister. What is important to note is that he is very much focused on…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
‘Steps in the right direction; a lot still needs to be done’
Rating: 3.5-4 / 10 Though the life sciences sector is yet to see ‘radical reforms’, the Narendra Modi Government’s efforts to…
‘We have to give time to set the wheels in motion’
Rating: 2.5/ 10 It is too early to be measure the impact that the new Government has had on the economy and markets. The Prime…
Analysing reactions to India’s draft pharma patent g’lines
Sankar Sundaram, pharmaceutical sciences professor at JSS University, Mysore and a patent agent with India's intellectual property…
Ashland Pharmaceutical Centre of Excellence conducts training programmes
Training will help the channel partners from India and other parts of Asia to understand the technology
Trapping The Ebola Virus
The Ebola outbreak has become a global emergency today. While a few drugs and vaccines are still under trial, the news of possible…
In Choppy Waters
Low investor sentiment, regulatory hurdles, drying pipelines are some of the challenges facing the biotech sector. It remains to…
‘We aim to stimulate biotech business in Gujarat’
Gujarat State Biotechnology Mission (GSBTM), a state-level nodal agency, coordinates the activities programme for encouraging and…
Accelerating growth: Forging India’s bioeconomy
Excerpts from a white paper that examines India’s biotech industry from different perspectives, with focus on biopharma and…
Merck Serono partners with Sutro Biopharma
Merck Serono to enhance its access to antibody drug conjugate technologies and to expand its oncology pipeline
Silver Leaf Oak acquires stake in Syngene International
Silver Leaf will acquire the stake from Biocon Research Limited (BRL), a wholly-owned subsidiary of Biocon at a valuation of Rs…
Health ministers adopt Dhaka Declaration on vector-borne diseases
Commit to control and eliminate vector-borne diseases
Cipla collaborates with S&D Pharma
To enter Czech Republic and Slovakia with affordable high quality alternatives
Roche and InterMune reach definitive merger agreement
Roche to fully acquire InterMune at a price of $74.00 per share
Wockhardt’s two anti-infective drugs get QIDP status from US FDA
WCK 771 is an intravenous (IV) drug while WCK 2349 is a solid oral tablet
Indian pharma excipients industry sets up IPEC India
IPEC India is the fifth member of the IPEC Federation
Novartis in pact with TB Alliance
As per agreement, NITD will fully transfer its TB R&D programme to TB Alliance
Cipla in agreement with Salix Pharmaceuticals
Cipla has granted Salix exclusive rights under certain patent applications in the ‘Rifaximin Complexes’ patent family
Strengthening product offerings to supplement existing portfolios drive M&A activity
Indian pharma sector witnesses no deals during August 2014